| The somatic genomic landscape of glioblastoma CW Brennan, RG Verhaak, A McKenna Cell 155 (2), 462-77, 2013 | 5358 | 2013 |
| Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma VRG TCGA Research Network, Noushmehr H, Iavarone A Cell 164 (3), 550-563, 2016 | 2177 | 2016 |
| The transferrin receptor and the targeted delivery of therapeutic agents against cancer TR Daniels, E Bernabeu, JA Rodríguez, S Patel, M Kozman, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1820 (3), 291-317, 2012 | 957 | 2012 |
| Nanomedicine therapeutic approaches to overcome cancer drug resistance JL Markman, A Rekechenetskiy, E Holler, JY Ljubimova Advanced drug delivery reviews 65 (13-14), 1866-1879, 2013 | 810 | 2013 |
| Mechanisms and barriers in cancer nanomedicine: addressing challenges, looking for solutions TJ Anchordoquy, Y Barenholz, D Boraschi, M Chorny, P Decuzzi, ... ACS nano 11 (1), 12-18, 2017 | 356 | 2017 |
| To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives D Shi, D Beasock, A Fessler, J Szebeni, JY Ljubimova, KA Afonin, ... Advanced drug delivery reviews 180, 114079, 2022 | 344 | 2022 |
| Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain LL Israel, A Galstyan, E Holler, JY Ljubimova Journal of Controlled Release 320, 45-62, 2020 | 286 | 2020 |
| Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy A Galstyan, JL Markman, ES Shatalova, A Chiechi, AJ Korman, R Patil, ... Nature Communications 10 (1), 3850, 2019 | 264 | 2019 |
| Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy? B Kateb, K Chiu, KL Black, V Yamamoto, B Khalsa, JY Ljubimova, H Ding, ... Neuroimage 54, S106-S124, 2011 | 237 | 2011 |
| Inhibition of brain tumor growth by intravenous poly (β-L-malic acid) nanobioconjugate with pH-dependent drug release H Ding, S Inoue, AV Ljubimov, R Patil, J Portilla-Arias, J Hu, B Konda, ... Proceedings of the National Academy of Sciences 107 (42), 18143-18148, 2010 | 202 | 2010 |
| Overexpression of α4 chain-containing laminins in human glial tumors identified by gene microarray analysis JY Ljubimova, AJ Lakhter, A Loksh, WH Yong, MS Riedinger, JH Miner, ... Cancer research 61 (14), 5601-5610, 2001 | 176 | 2001 |
| Fulminant hepatic failure in rats: survival and effect on blood chemistry and liver regeneration S Eguchi, A Kamlot, J Ljubimova, WR Hewitt, LT Lebow, AA Demetriou, ... Hepatology 24 (6), 1452-1459, 1996 | 154 | 1996 |
| Near-infrared imaging of brain tumors using the Tumor Paint BLZ-100 to achieve near-complete resection of brain tumors PV Butte, A Mamelak, J Parrish-Novak, D Drazin, F Shweikeh, ... Neurosurgical focus 36 (2), E1, 2014 | 153 | 2014 |
| Overexpression of matrix metalloproteinase-10 and matrix metalloproteinase-3 in human diabetic corneas: a possible mechanism of basement membrane and integrin alterations M Saghizadeh, DJ Brown, R Castellon, M Chwa, GH Huang, ... The American journal of pathology 158 (2), 723-734, 2001 | 137 | 2001 |
| Polycefin, a New Prototype of a Multifunctional Nanoconjugate Based on Poly(β-l-malic acid) for Drug Delivery BS Lee, M Fujita, NM Khazenzon, KA Wawrowsky, S Wachsmann-Hogiu, ... Bioconjugate chemistry 17 (2), 317-326, 2006 | 134 | 2006 |
| Nanoconjugate based on polymalic acid for tumor targeting JY Ljubimova, M Fujita, NM Khazenzon, BS Lee, S Wachsmann-Hogiu, ... Chemico-biological interactions 171 (2), 195-203, 2008 | 128 | 2008 |
| Ambiguities in Applying Traditional Limulus Amebocyte Lysate Tests to Quantify Endotoxin in Nanoparticle Formulations MA Dobrovolskaia, BW Neun, JD Clogston, H Ding, J Ljubimova, ... Nanomedicine 5 (4), 555-562, 2010 | 127 | 2010 |
| Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines J Szebeni, G Storm, JY Ljubimova, M Castells, EJ Phillips, K Turjeman, ... Nature nanotechnology 17 (4), 337-346, 2022 | 124 | 2022 |
| Poly (malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery JY Ljubimova, M Fujita, AV Ljubimov, VP Torchilin, KL Black, E Holler Nanomedicine 3 (2), 247-265, 2008 | 117 | 2008 |
| Brain tumor tandem targeting using a combination of monoclonal antibodies attached to biopoly (β-L-malic acid) M Fujita, BS Lee, NM Khazenzon, ML Penichet, KA Wawrowsky, R Patil, ... Journal of Controlled Release 122 (3), 356-363, 2007 | 116 | 2007 |
